MDA-MB-231 cells were maintained in Iscove's modified Dulbecco's medium (Life Technologies, Carlsbad, CA) with 10% fetal bovine serum (FBS) and an antibacterial-antimycotic cocktail (Gemini Bio-Products, West Sacramento, CA). SUM159PT cells were maintained in F-12 medium (Life Technologies) with 5% FBS, 5 μg/ml insulin, 1 μg/ml hydrocortisone, and an antibacterial-antimycotic cocktail.
